Opthea (OPT) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Opthea, with shares still suspended, cuts workforce by 65% after drug trials cancelledApril 9, 2025 | msn.comRegal Partners shares slide on drop in funds under managementApril 9, 2025 | msn.comHealth Check: It’s a CEO changing of the guard at Mach 7 and Universal BiosensorsMarch 31, 2025 | msn.comOpthea in active talks with funders after second trial failsMarch 31, 2025 | afr.comWhy this sold-off ASX All Ords dividend stock is 'well placed to generate long-term shareholder value'March 27, 2025 | msn.comHedge Fund Regal Among Stock Pickers Burned by Biotech CrashMarch 27, 2025 | bloomberg.comJefferies Downgrades Opthea Limited - Depositary Receipt () (OPT)March 26, 2025 | msn.comOpthea downgraded to Neutral from Buy at H.C. WainwrightMarch 25, 2025 | markets.businessinsider.comTrading in Opthea Still Halted After Phase 3 Study FailureMarch 25, 2025 | marketwatch.comOpthia could owe $1bn to investors amid sozinibercept trial failureMarch 25, 2025 | msn.comInvestors fret over clinical trial failure’s hit on Regal fundsMarch 24, 2025 | afr.comOpthea Ltd (ADR) trading halted, news pendingMarch 17, 2025 | markets.businessinsider.comTrading in Opthea Halted Ahead of Update on Wet AMD StudyMarch 17, 2025 | marketwatch.comIt’s Phil King’s Regal against the shorts at biotech play OptheaMarch 17, 2025 | afr.com10 Best Australian Stocks to Buy According to BillionairesMarch 11, 2025 | insidermonkey.comOpthea First Half 2025 Earnings: US$0.11 loss per share (vs US$0.17 loss in 1H 2024)March 5, 2025 | finance.yahoo.comWilsons upgrades Opthea Limited (CKDXF) to a HoldFebruary 20, 2025 | markets.businessinsider.comOpthea Completes COAST Final Week 52 Patient VisitFebruary 18, 2025 | markets.businessinsider.comIs Opthea Limited (OPT) the Best Long Term ASX Stock to Buy Now?February 11, 2025 | msn.comOpthea to present at upcoming healthcare conferenceFebruary 7, 2025 | msn.comOpthea Wet AMD Data Featured at Macula Society MeetingFebruary 6, 2025 | markets.businessinsider.comOpthea presents Wet AMD data at Macula Society MeetFebruary 6, 2025 | msn.comOpthea Ltd stock soars to 52-week high, hits $5.48January 30, 2025 | msn.comAnalysts Offer Insights on Healthcare Companies: Sagimet Biosciences, Inc. Class A (SGMT) and Blueprint Medicines (BPMC)January 27, 2025 | markets.businessinsider.comWhy this speculative ASX stock could rocket 70%January 16, 2025 | msn.comBell Potter Sticks to Its Buy Rating for Opthea Limited (CKDXF)January 15, 2025 | markets.businessinsider.comOpthea to host investor days in New York, AustraliaJanuary 9, 2025 | markets.businessinsider.comChartWatch ASX Scans: Eagers Automotive, Opthea, Paradigm Biopharma, Qantas, Tasmea, Trigg Minerals, Xero, Champion Iron, FortescueJanuary 7, 2025 | msn.comOpthea announces publication on Phase 1b trial of sozinibercept in DMEJanuary 7, 2025 | markets.businessinsider.comOpthea Announces Publication in Diabetic Macular EdemaJanuary 7, 2025 | markets.businessinsider.comHealth Check: New JV for Opyl; Dimerix inks another licensing dealJanuary 7, 2025 | msn.comBiotech smallcap Opthea eyes 5% jump as key drug of interest validated in paperJanuary 7, 2025 | msn.comOpthea’s Promising Results in Diabetic Macular Edema Trial PublishedJanuary 7, 2025 | markets.businessinsider.comOpthea Limited Updates Director’s StakeholdingDecember 17, 2024 | markets.businessinsider.comHealth Check: It’s a wipe out! Percheron shares tumble up to 91pc on rare genetic disease trial failureDecember 17, 2024 | msn.comWhy Healius, Opthea, Peninsula Energy, and Wildcat shares are falling todayNovember 14, 2024 | msn.comOpthea Limited Announces Successful AGM ResolutionsNovember 14, 2024 | markets.businessinsider.comOpthea Secures A$15.9 Million Boost for R&D EffortsNovember 14, 2024 | markets.businessinsider.comOpthea Limited Advances Vision Treatment Amid Market ChallengesOctober 28, 2024 | markets.businessinsider.comIs Opthea Limited (OPT) the Penny Stock with the Biggest Upside Potential According to Analysts?October 16, 2024 | msn.comOpthea Files Notice of Annual General MeetingOctober 16, 2024 | markets.businessinsider.comOpthea Appoints Appoints Parisa Zamiri As Chief Medical Officer, Tom Reilly As CFOOctober 8, 2024 | markets.businessinsider.com'Exciting prospect': 2 ASX pharmaceutical shares to keep a close eye onOctober 1, 2024 | msn.comOpthea Limited’s Sozinibercept: A Promising Therapy for wAMD with Strong Financial BackingSeptember 27, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Marinus (MRNS) and Opthea Limited (OtherCKDXF)September 23, 2024 | markets.businessinsider.comWhy Appen, Lotus, Opthea, and Paladin Energy shares are surging todaySeptember 22, 2024 | msn.comOpthea Limited: Strong Buy Rating on Manufacturing Milestones and Positive Financial OutlookSeptember 19, 2024 | markets.businessinsider.comOpthea Ltd Key Opinion Leader Event On Sozinibercept In Wet Age Related Macular Degeneration ...September 14, 2024 | gurufocus.comAlive and Kicking: ‘We are not alone in going through a lull in markets’, says Clinuvel chairSeptember 8, 2024 | msn.comAllakos Inc. (37Z.MU)August 23, 2024 | finance.yahoo.com Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address OPT Media Mentions By Week OPT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPT News Sentiment▼0.801.03▲Average Medical News Sentiment OPT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPT Articles This Week▼01▲OPT Articles Average Week Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AKRO News SWTX News SRRK News OGN News CRNX News MRUS News VKTX News XENE News MOR News CPRX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:OPT) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opthea Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Opthea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OPT Stock Free OPT Stock Alerts